These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New year, new option: Cyclo-Provera awaits word. Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212 [TBL] [Abstract][Full Text] [Related]
4. Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Fraser IS Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222 [TBL] [Abstract][Full Text] [Related]
5. Long-acting steroids provide new options. Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656 [TBL] [Abstract][Full Text] [Related]
6. Millions of couples to have choice of injectable contraceptive. Integration; 1996; (47):41. PubMed ID: 12347310 [TBL] [Abstract][Full Text] [Related]
7. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell]. Greenspan A Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540 [TBL] [Abstract][Full Text] [Related]
8. Adolescent knowledge and use of injectable contraceptives in developing countries. Singh S J Adolesc Health; 1995 May; 16(5):396-404. PubMed ID: 7662691 [TBL] [Abstract][Full Text] [Related]
9. Statement on injectable contraception. Revised. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921 [TBL] [Abstract][Full Text] [Related]
10. Injectable contraceptives: how safe are they? Initiatives Popul; 1979; 5(4):2-10. PubMed ID: 12338524 [TBL] [Abstract][Full Text] [Related]
11. Systemics. Netw Res Triangle Park N C; 1985; 6(3):1-3. PubMed ID: 12280131 [TBL] [Abstract][Full Text] [Related]
13. Depo Provera: still controversial. Wren LM Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873 [TBL] [Abstract][Full Text] [Related]
14. Are Norplant, Depo-Provera good options for nursing mothers? Contracept Technol Update; 1993 Mar; 14(3):46-8. PubMed ID: 12318085 [TBL] [Abstract][Full Text] [Related]
15. FDA gives final approval to Depo amid concerns over safety, cost and coercion. Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620 [TBL] [Abstract][Full Text] [Related]
16. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects. Basnayake S; Thapa S Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188 [TBL] [Abstract][Full Text] [Related]
17. [Our regions evaluate the program. Contraception by injectable progestin, Depo Provera: opportunity, continuity and analyses of the situation in central west Tunisia]. Khelifi A Majallat Aldiwan Alqawmi Lilusrah Waal Umran lbashari; 1997 Sep; (6):16-7. PubMed ID: 12293313 [TBL] [Abstract][Full Text] [Related]
18. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya. Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854 [TBL] [Abstract][Full Text] [Related]
19. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. London RS J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530 [TBL] [Abstract][Full Text] [Related]
20. Injectable contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]